Understanding Risk Factors for Opioid Overdose in Clinical Populations to Inform Treatment and Policy

@article{Park2016UnderstandingRF,
  title={Understanding Risk Factors for Opioid Overdose in Clinical Populations to Inform Treatment and Policy},
  author={Tae Woo Park and Lewei Allison Lin and Avinash Hosanagar and Amanda Kogowski and Katie Paige and Amy S B Bohnert},
  journal={Journal of Addiction Medicine},
  year={2016},
  volume={10},
  pages={369–381}
}
Overdoses involving opioid analgesics represent a significant public health problem in the United States. We reviewed the literature on risk factors for overdose, with a focus on studies that examine clinical populations of patients receiving opioids for pain and potential risk factors for overdose in these populations. A structured review resulted in 15 articles published between 2007 and 2015 that examined risk factors for fatal and nonfatal overdose in patients receiving opioid analgesics… 
View on Wolters Kluwer
static1.squarespace.com
46 Citations
Highly Influential Citations
1
Background Citations
15
Methods Citations
2
Results Citations
2

46 Citations

Association of Opioid Overdose Risk Factors and Naloxone Prescribing in US Adults

Naloxone prescribing has increased and was more likely to be co-prescribed to patients with some risk factors for overdose, however, overall prescribing remains minimal.

New and Emerging Opioid Overdose Risk Factors

The purpose of this review is to provide a review of the current literature surrounding opioid overdose risk factors, focusing on relatively new factors in the opioid crisis. Both a market supply…

Patient Preference for Pain Medication in the Emergency Department Is Associated with Non-fatal Overdose History

Patients with a pain medication preference have higher odds of having a lifetime overdose compared to patients without a specific pain medications preference, even after accounting for level of opioid misuse.

The risks of opioid treatment: Perspectives of primary care practitioners and patients from safety-net clinics.

To improve the informed consent process for opioid therapy, patients and PCPs need to have a shared understanding of the risks of opioids and engage in discussions that promote patient autonomy and safety.

Opioid Overdose in the Hospital Setting: A Systematic Review.

Improved detection methods are needed to more accurately measure the rate of inpatient opioid overdose, and refined estimates of opioid overdose should be used to drive safety and quality improvement initiatives in hospitals.

Prescribing, Prescription Monitoring, and Health Policy

Major initiatives are in place to promote treatment of persons with opioid use disorder and to reduce the harm associated with opioid misuse, and national legislation to improve funding for addiction treatment.

Non-fatal overdose risk during and after opioid agonist treatment: A primary care cohort study with linked hospitalisation and mortality records

Changing Trends in Opioid Overdose Deaths and Prescription Opioid Receipt Among Veterans.

Opioid Overdoses in Indiana: A Closer Look at Opioid Type

Until recently, prescription opioids were responsible for the greatest number of overdose deaths across the country, but now have been surpassed by those from heroin and illicitly manufactured narcotics, primarily fentanyl.

The role of substance use disorders in experiencing a repeat opioid overdose, and substance use treatment patterns among patients with a non-fatal opioid overdose.

References

SHOWING 1-10 OF 40 REFERENCES

Prescription opioid duration of action and the risk of unintentional overdose among patients receiving opioid therapy.

The findings of the present study provide the first evidence that the risk of unintentional overdose injury is related to the prescribed opioid's duration of action, and suggest that clinicians weighing the benefits and risks of initiating different opioid regimens should consider not only the daily dose prescribed but also the duration of opioid action, favoring short-acting agents whenever possible, especially during the first 2 weeks of therapy.

Low Use of Opioid Risk Reduction Strategies in Primary Care Even for High Risk Patients with Chronic Pain

Primary care physicians’ adoption of opioid risk reduction strategies is limited, even among patients at increased risk of misuse, and an increasing number of risk factors was positively associated with urine drug testing, but negatively associated with restricted early refills.

An analysis of the root causes for opioid-related overdose deaths in the United States.

Clinical strategies to reduce opioid-related mortality should be empirically tested, should not reduce access to needed therapies, should address risk from methadone as well as other opioids, and should be incorporated into any risk evaluation and mitigation strategies enacted by regulators.

Risk factors for serious prescription opioid-related toxicity or overdose among Veterans Health Administration patients.

Screening patients for risk, providing education, and coprescribing naloxone for those at elevated risk may be effective at reducing serious opioid-related respiratory/CNS depression and overdose in medical users of prescription opioids.

Personalized medicine and opioid analgesic prescribing for chronic pain: opportunities and challenges.

Opioid Prescriptions for Chronic Pain and Overdose

Patients receiving higher doses of prescribed opioids are at increased risk for overdose, which underscores the need for close supervision of these patients.

Assessing risk for drug overdose in a national cohort: role for both daily and total opioid dose?

  • Yuanyuan LiangB. Turner
  • Medicine, Psychology
    The journal of pain : official journal of the American Pain Society
  • 2015

CDC Guideline for Prescribing Opioids for Chronic Pain--United States, 2016.

This guideline is intended to improve communication about benefits and risks of opioids for chronic pain, improve safety and effectiveness of pain treatment, and reduce risks associated with long-term opioid therapy.

Opioid dose and drug-related mortality in patients with nonmalignant pain.

Among patients receiving opioids for nonmalignant pain, the daily dose is strongly associated with opioid-related mortality, particularly at doses exceeding thresholds recommended in recent clinical guidelines.

High-risk use by patients prescribed opioids for pain and its role in overdose deaths.

Use of prescription drug–monitoring program data to direct risk-reduction measures to the types of patients overrepresented among overdose deaths might reduce mortality associated with opioid abuse.